Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 21,662,000 | 20,063,000 | 18,676,000 | 17,265,000 | 15,582,000 |
| Cost of Goods | 4,227,000 | 4,422,000 | 3,346,000 | 3,199,000 | 2,708,000 |
| Gross Profit | 17,435,000 | 15,641,000 | 15,330,000 | 14,066,000 | 12,874,000 |
| Operating Expenses | 8,965,000 | 9,450,000 | 9,463,000 | 8,489,000 | 8,562,000 |
| Operating Income | 8,470,000 | 6,191,000 | 5,867,000 | 5,577,000 | 4,312,000 |
| Interest Expense | 1,095,000 | 1,071,000 | 1,022,000 | 1,053,000 | 610,000 |
| Other Income | 603,000 | 465,000 | 420,000 | 485,000 | 448,000 |
| Pre-tax Income | 7,978,000 | 5,585,000 | 5,265,000 | 5,009,000 | 4,150,000 |
| Income Tax | 1,039,000 | 427,000 | 184,000 | 664,000 | 467,000 |
| Net Income Continuous | 6,939,000 | 5,158,000 | 5,081,000 | 4,345,000 | 3,683,000 |
| Net Income | $6,939,000 | $5,158,000 | $5,081,000 | $4,345,000 | $3,683,000 |
| EPS Basic Total Ops | 9.15 | 6.80 | 6.75 | 5.61 | 4.07 |
| EPS Basic Continuous Ops | 9.15 | 6.80 | 6.75 | 5.61 | 4.07 |
| EPS Diluted Total Ops | 9.06 | 6.70 | 6.64 | 5.52 | 4.04 |
| EPS Diluted Continuous Ops | 9.06 | 6.70 | 6.64 | 5.52 | 4.04 |
| EBITDA(a) | $10,578,000 | $8,283,000 | $7,153,000 | $6,665,000 | $5,372,000 |